Drug news
Nordic rights to ReFacto and BeneFIX are returned to Pfizer
Pfizer has taken back the Nordic territory rights to reclaim to the blood clotting factors ReFacto and BeneFIX from Swedish Orphan Biovitrum which held co-promotion rights there.The drugs will continue to be manufactured in Sweden.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.